Skip to content

Study to Determine the Effectiveness of Pillar Palatal Implants to Treat Obstructive Sleep Apnea

Pillar Palatal Implant System Multi-Institutional, Randomized Placebo-Controlled Study for Obstructive Sleep Apnea

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00307957
Enrollment
100
Registered
2006-03-28
Start date
2005-10-31
Completion date
2006-10-31
Last updated
2007-12-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive Sleep Apnea

Keywords

Obstructive Sleep Apnea, Daytime Sleepiness, Pillar Palatal Implants

Brief summary

The Pillar palatal implant procedure is a minimally invasive and commercially available treatment for mild to moderate obstructive sleep apnea (OSA) in the United States and Europe. The implants are placed into the soft area in the roof of the mouth providing support to the soft palate. This research is being done to compare daytime sleepiness and sleep related quality of life after palatal implants.

Detailed description

Patients will be enrolled into the study based on sleep study results, a physical exam and inclusion/exclusion criteria. Once enrolled, patients are randomized into either the Pillar palatal implant group or a placebo/sham group. In both cases, patients come into the office for placement of the implants. This is an outpatient procedure. Patients are followed at one week, one month and 3 months. At each follow-up visit, patients will undergo a physical exam and complete questionnaires related to sleep and quality of life. Patients will also undergo reaction time testing on hand-held device similar to a pocket video game. At the three month visit, patients will return to the sleep lab for another sleep study.

Interventions

DEVICEPillar Palatal Implants

Sponsors

Medtronic Xomed, Inc.
CollaboratorINDUSTRY
University of Cincinnati
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* 18 years or older * Body Mass Index equal to 32 or less * Apnea-Hypopnea Index greater than/equal to 10 and less than/equal to 30 * Symptoms of daytime sleepiness

Exclusion criteria

* Septal deviation or nasal obstruction * Nasal polyps * Severe seasonal allergies * Soft palate length insufficient to accommodate implants * Fujita Modified Mallampati Class 3 * Large tonsils * Lingual tonsil hypertrophy * Hypopharyngeal obstruction * Previous pharyngeal surgery * Previous upper respiratory tract cancer or radiation therapy * Active respiratory tract infection * Dysphagia or speech disorder * Neurologic disorder * Unstable psychiatric disorder * Pregnant or breastfeeding * History of falling asleep driving or MVA due to sleepiness * Currently on CPAP therapy or other device for OSA * Other sleep disorders

Design outcomes

Primary

MeasureTime frame
Daytime Sleepiness (ESS)
Apnea/Hypopnea Index (AHI)

Secondary

MeasureTime frame
Sleep Related Quality of Life (FOSQ)
Reaction Time Testing (PVT)
Other polysomnographic parameters (AI, HI, RERArl, Arl, LSat)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026